Published in
Impact Journals, Oncotarget, 41(8), p. 69651-69662, 2017
DOI: 10.18632/oncotarget.18753
Links
Tools
A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196
Journal article published in 2017 by
Natasha B. Leighl,
Ming-Sound Tsao 
,
Geoffrey Liu,
Dongsheng Tu,
Cheryl Ho,
Frances A. Shepherd,
Nevin Murray,
John R. Goffin,
Garth Nicholas,
Shingo Sakashita,
Zhuo Chen,
Lucia Kim,
Jean Powers,
Lesley Seymour,
Glenwood Goss
and other authors.
,
Geoffrey Liu,
Dongsheng Tu,
Cheryl Ho,
Frances A. Shepherd,
Nevin Murray,
John R. Goffin,
Garth Nicholas,
Shingo Sakashita,
Zhuo Chen,
Lucia Kim,
Jean Powers,
Lesley Seymour,
Glenwood Goss
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 